Published on 03.08.17 in Vol 5, No 8 (2017): August
The Impact of Text Messaging on Medication Adherence and Exercise Among Postmyocardial Infarction Patients: Randomized Controlled Pilot Trial
Background: Adherence to evidence-based therapies such as medications and exercise remains poor among patients after a myocardial infarction (MI). Text message reminders have been shown to improve rates of adherence to medication and exercise, but the existing studies have been of short duration.
Objective: Two single-center randomized controlled pilot trials were conducted to evaluate the impact of text message reminders over 12 months on adherence to cardiac medications and exercise among patients receiving cardiac rehabilitation after hospitalization for MI.
Methods: In the medication adherence trial, 34 patients were randomized to receive usual care alone or usual care plus daily text message reminders delivered at the time of day at which medications were to be taken. In the exercise adherence trial, 50 patients were randomized to receive usual care alone or usual care plus 4 daily text messages reminding them to exercise as directed.
Results: The text message reminders led to a mean 14.2 percentage point improvement in self-reported medication adherence over usual care (P<.001, 95% CI 7-21). In the exercise trial, text message reminders resulted in an additional 4.2 days (P=.001, 95% CI 1.9-6.4) and 4.0 hours (P<.001, 95% CI 2.4-5.6) of exercise per month over usual care and a nonsignificant increase of 1.2 metabolic equivalents (METS; P=.06) in exercise capacity as assessed by a BRUCE protocol at 12 months.
Conclusions: Text message reminders significantly increased adherence to medication and exercise among post-MI patients receiving care in a structured cardiac rehabilitation program. This technology represents a simple and scalable method to ensure consistent use of evidence-based cardiovascular therapies.
Trial Registration: Clinicaltrials.gov NCT02783287; https://clinicaltrials.gov/ct2/show/NCT02783287 (Archived by WebCite at http://www.webcitation.org/6sBnvNb05)
JMIR Mhealth Uhealth 2017;5(8):e110
Acute myocardial infarction (MI) remains a leading cause of death and disability worldwide . The use of evidence-based therapies, including exercise and medications, has contributed to substantial reductions in cardiovascular morbidity and mortality [ ]. Whereas the prescription of these highly effective therapies is now nearly universal, many patients do not adhere to their medications or exercise regimens over the long term, which in turn is associated with negative consequences for cardiovascular outcomes and spending [ - ].
Although many factors are associated with such gaps in care, simple forgetfulness has been identified as a key contributor [- ]. Strategies to address this barrier include improvements to pillboxes and bottles, including manual and electronic reminder systems; however, only a few have been rigorously evaluated and, in some cases, their complexity, cost, and the need for patients to purchase and set them up to use them may limit their ultimate value [ - ].
With the widespread use of mobile phones, including the recent increase in uptake among elderly patients, text message–based reminders may represent a potentially effective avenue for intervention [- ]. Although some clinical benefit from text message reminders has been established in improving both medication and exercise adherence, there is little evidence about the effectiveness of this strategy for patients recently discharged after MI [ - ], which represents a particularly high-risk patient subgroup [ ]. The few studies that do exist have been of limited duration, with the longest study among post-MI patients being of an 8-week duration only. Accordingly, we sought to assess the impact of structured daily text message reminders on adherence to post-MI medications and exercise in two randomized controlled pilot trials.
To assess the impact of text message reminders on adherence to medications and exercise, we conducted two single-center, open-label, randomized controlled pilot trials in patients recently discharged from hospital after MI. This research was approved by the University of Waterloo Research Ethics Committee (20980) and is registered with clinicaltrials.gov (NCT02783287).
The trials were conducted at Cambridge Cardiac Rehab in Ontario, Canada, which enrolled consecutive patients aged 18 years and older, who within the preceding 2 weeks had been discharged from hospital after MI and enrolled in a structured cardiac rehabilitation program. In the medication adherence trial, we included patients who were receiving treatment with medications from all four of the following classes: antiplatelets, beta-blockers, angiotensin converting enzyme inhibitors-I or angiotensin receptor blockers, and 3-hydroxy-3-methylglutaryl- coenzyme reductase enzyme inhibitors (statins). As the trial involved daily text messaging, patients taking medications in dosing regimens of more than once daily were excluded. In the exercise adherence trial, we included patients who had been prescribed an exercise regimen comprising 45 min of exercise 5 days a week. In both trials, individuals without a mobile phone, those who were unable to read and write in English or provide informed consent, or those who were incarcerated were excluded.
In both trials, following recruitment and written informed consent, we collected demographic information, including age, gender, medical diagnosis, medication list, and educational status. Participants were randomized using a Web-based random number generator in a 1:1 ratio to intervention or control. Patients were not permitted to participate in both trials.
In the medication adherence trial, patients randomized to intervention received daily text messages at the time they preferred to take their medications. The text messages simply indicated that patients should remember to take their medications and contained no identifiable information such as medications names or classes. For example, patients who took their medication in the morning received a text message that read, “Please remember to take your morning medications now.” Patients randomized to the control arm of the study did not receive text reminders. Automated text message reminder software was developed with Microsoft Small Basic, a simplified version of Microsoft Visual Basic, and did not utilize bidirectional contact.
For the exercise adherence trial, patients randomized to the intervention group were sent text message reminders 4 times daily, at 7:30 am, 12:00 pm, 6:00 pm, and 9:00 pm. The text message reminders simply read, “Please remember to exercise for 30 minutes today.” These timings were identified as common timings for exercise by the staff of the cardiac rehabilitation center where the study was conducted. Patients randomized to the control arm of the study did not receive any text message reminders.
All patients in both trials participated in the structured outpatient cardiac rehabilitation program in which they were enrolled. The program comprised 1 week of education about diet, proper exercise technique, heart disease and MI, smoking cessation, and stress management and was followed by 2 sessions per week of on-site exercise under the supervision of kinesiologists and nurses. The study protocol was conducted with the help of the staff at the study site. Cardiac rehabilitation nurses and kinesiologists distributed and collected logbooks and enrolled patients into the text message reminder system. After completing the initial 3 months of the program, patients continued their rehabilitation at home but were instructed to return for a follow-up assessment at 1 year. In both trials, patients were followed up for up to 12 months, including the 3 initial months of the program, and patients and their health care providers were aware of the arm to which they had been randomized.
In the adherence trial, all study participants were asked to use a logbook to record the name and timing of the medications they had taken on a daily basis. The logbooks were based on the standard logbooks used by the cardiac rehabilitation center as suggested by The Canadian Association of Cardiovascular Prevention and Rehabilitation. The logbooks had 1 page per day, with separate rows for different times of the day. Patients were instructed not to log anything if they missed a medication or did not exercise on a specific day. Missing entries were interpreted as a missed dose. Logbooks were collected monthly. From these logs, absolute medication adherence was calculated as the percentage of total prescribed doses that were actually taken each month. For example, if a patient took 27 out of the 30 prescribed doses for a month, they were deemed to be 90% adherent. The primary outcome for this trial was average adherence over 12 months, calculated as the mean of each of the 12 monthly measurements of the percentage of days covered (PDC). The secondary outcome was “full adherence,” which was a measure of whether average adherence over the 12 months of follow-up was greater than 80%, which in turn represented a level of use above which patients with coronary artery disease benefit from statins and the threshold used by most quality measures [- ].
In the exercise trial, all participants were asked to log the time when they started and finished exercising every day. Logbooks were collected on a monthly basis. The primary outcome for this trial was the average number of days per month that a patient exercised over 12 months, calculated as the mean of each of the 12 monthly measurements of the days per months exercised. Secondary outcomes included the average number of hours of exercise per month and cardiopulmonary fitness as assessed by a BRUCE protocol 12 months after randomization [, ]. Cardiopulmonary fitness was evaluated with an exercise stress test conducted according to the BRUCE protocol, which is the most widely used method employed in routine clinical practice. In this approach, patients walk on a treadmill and the speed and inclination are adjusted based on a preset schedule. Patients walk until they are unable to continue or are instructed to stop by the technician conducting the test. The duration of time that elapses before stopping is then converted to metabolic equivalents (METS) based on standard calculations.
Sample sizes for the trials were estimated based on the results of two preparatory studies conducted at the Cambridge Cardiac Care Center. The medication adherence study was a 2-month crossover study of 30 patients who were recently discharged from hospital after admission for coronary artery disease; these patients were randomized to receive text message reminders for 1 month and to receive no text message reminders the other month. The exercise adherence study was a 2-month parallel group study of 16 post-MI patients who were randomized to either receive daily text message reminders or not to receive daily text message reminders for 2 months. The medication adherence pilot found a 10.8 percentage point (standard deviation [SD] 8.9) increase in adherence from text message reminders. On the basis of this increase in adherence, and assuming an alpha of .05, we estimated that we could achieve 80% power with a sample size of at least 32 patients. The exercise adherence pilot trial found an increase of 10.3 (SD 18.7) days per month of exercise; on the basis of this increase and assuming an alpha of .05, we estimated that we could achieve 80% power with a sample size of 50 patients.
All analyses were performed based on the intention-to-treat principles. We calculated means and frequencies of prerandomization variables separately by study arm. For the medication adherence trial, we evaluated the impact of text messaging on average adherence and optimal adherence using linear and logistic regression, respectively. For the exercise adherence trial, all outcomes were evaluated using linear regression. After performing these analyses, we ran multivariable models adjusting for characteristics that were imbalanced by chance at baseline.
We additionally conducted hypothesis-generating subgroup analyses on the following factors: sex, age >65 years versus ≤65 years, postsecondary education versus up to postsecondary education, and self-reported depression versus no depression at baseline. Specifically, we evaluated whether model-based interaction terms were statistically significant for the primary outcome. We used Statistical Analysis System version 9.4 for all statistical analyses.
We screened a total of 90 patients discharged from hospital after acute MI, of whom 56 (63%) did not meet study inclusion criteria or declined to participate (). The remaining 34 were randomly assigned to receive usual care alone (control) or usual care plus text message reminders (intervention). One control patient withdrew from the study during the first month of the study. Baseline characteristics of the study participants are shown in . Intervention subjects were slightly older, more likely to be smokers, taking more medications at baseline, and female. Baseline adherence before the beginning of the study was not measured. At month 1, patients in the control group achieved 90% medication adherence.
The impact of text messaging on medication adherence is shown inand . The average medication adherence during follow-up for patients randomized to usual care was 80% (95% CI 73-86). The mean difference in PDC between the text message and control groups was 14.2 percentage points (95% CI 7-21, P<.001; ). All intervention patients were optimally adherent to their prescribed medications during follow-up compared with 50% (8/16) of control patients (P<.001). The results remained unchanged in a multivariable model adjusting for differences in sex, the only characteristic that was statistically significantly imbalanced at baseline.
|Characteristic||Adherence trial||Exercise trial|
|Text message |
|Usual care (N=16)||Text message |
|Usual care (N=25)|
|Age in years, mean (SD)||64.6 (11.5)||62.1 (11.0)||64.3 (10.7)||63.7 (9.6)|
|Male gender, n (%)||6 (35)||14 (88)||15 (60)||11 (44)|
|Secondary school, n (%)||10 (67)||8 (50)||17 (71)||16 (64)|
|Postsecondary school, n (%)||5 (33)||8 (50)||7 (29)||9 (36)|
|Cancer, n (%)||1 (6)||1 (6)||2 (8)||1 (4)|
|COPDb, n (%)||3 (18)||3 (19)||4 (16)||5 (20)|
|Dementia, n (%)||3 (18)||2 (13)||5 (20)||4 (16)|
|Depression (self-report), n (%)||6 (35)||6 (38)||12 (48)||10 (40)|
|Diabetes, n (%)||6 (35)||7 (44)||10 (40)||8 (32)|
|Heart failurec, n (%)||-||-||10 (40)||9 (36)|
|Chronic kidney disease, n (%)||2 (12)||3 (19)||6 (24)||5 (20)|
|Smoker, n (%)||7 (41)||4 (25)||10 (40)||9 (36)|
|Stroke, n (%)||4 (24)||1 (6)||4 (16)||3 (12)|
|Baseline BRUCEc, mean (SD)||-||-||5.0 (1.7)||5.1 (1.9)|
|Number of medicationsd, mean (SD)||10.1 (4.5)||8.0 (5.2)||10.5 (4.6)||9.0 (6.1)|
a2 patients missing from Adherence trial, intervention arm; 1 patient missing from Exercise trial, intervention arm.
bCOPD: chronic obstructive pulmonary disease.
cNot collected for Adherence trial.
d1 patient missing from Adherence trial, control arm.
|Trial and outcome||Parameter||Text message |
|Usual care |
|Primary||Average percentage of days covered during follow-up||94 (92-96)||80 (73-86)||14 (7-21)||<.001|
|Secondary||Percentage (N) fully adherent during follow-up||100 (17)||50 (8)||50||<.001b|
|Primary||Mean days of exercise per month during follow-up||17.2 (16.0-18.5)||13.1 (11.1-15.0)||4.2 (1.9-6.4)||.001|
|Secondary||Mean hours of exercise per month during follow-up||12.5 (11.5-13.6)||8.5 (7.3-9.8)||4.0 (2.4-5.6)||<.001|
|Cardiopulmonary fitness at month 12 (METS)c||7.4 (6.5-8.3)||6.2 (5.2-7.2)||1.2 (−0.1 to 2.5)||.06|
aSatterthwaite method, except where noted.
bFisher exact test.
cMETS: metabolic equivalents, where 1 MET is equal to a whole-body oxygen consumption of 3.5 mL O2/kg/min.
|Trial and subgroup||Text message |
|Usual care (N)||Absolute difference||P valuea|
|Adherence outcome: percentage of days covered|
|Male||93 (6)||80 (14)||13||.95|
|Female||94 (11)||81 (12)||13||.95|
|Age >65 years||91 (7)||73 (8)||18||.01|
|Age ≤65 years||96 (10)||85 (8)||11||.01|
|>12 years of education||94 (5)||82 (8)||12||.60|
|<12 years of education||93 (10)||77 (8)||16||.60|
|Depression (self-report)||95 (6)||79 (6)||16||.95|
|No depression||94 (11)||80 (10)||14||.95|
|Exercise outcome: days of exercise per month|
|Male||16.8 (15)||11 (11)||5.8||.38|
|Female||19.2 (10)||10.5 (14)||8.7||.38|
|Age >65 years||18.2 (12)||12 (11)||6.2||.15|
|Age ≤65 years||16 (13)||14.2 (14)||1.8||.15|
|>12 years of education||17.5 (7)||13.9 (9)||3.6||.74|
|<12 years of education||17.1 (17)||12.6 (16)||4.5||.74|
|Depression (self-report)||18.4 (12)||12.6 (10)||5.8||.31|
|No depression||15.8 (13)||12.7 (15)||3.1||.31|
aRegression model-based interaction term.
Adherence was consistently higher for patients randomized to receive text messages across all subgroups but was statistically significantly only for age (). Text messages increased adherence by an average of 18% among patients ≥65 years of age compared with 11% among patients younger than 65 years (P value for interaction .009).
We screened a total of 92 patients discharged from hospital after an acute MI (). Of these, 42 were ineligible to participate in the study. The remaining 50 patients were randomized to either receive usual care or usual care in addition to text message reminders.
Baseline characteristics of the study participants are shown in. As in the medication adherence trial, intervention subjects tended to be older, more likely to smoke, and, on average, taking more medications at baseline. Additionally, intervention subjects were more likely to be female but were similar to controls with respect to cardiopulmonary fitness. Baseline exercise behavior before the beginning of the study was not observed. At month 1, patients in the control group exercised on an average of 16.7 days per month.
The impact of text messaging on exercise adherence is shown inand . The patients assigned to usual care exercised on an average of 13.1 days per month. In the text message group, the average number of days of exercise per month increased by 4.2 days (95% CI 1.9-6.4) to 17.2 days (P<.001). In multivariable models adjusting for imbalances in baseline characteristics, the results remained unchanged.
Patients receiving text messages also exercised an additional 4.0 hours per month (P<.001) and had a nonstatistically significant increase of 1.2 METS (P=.06) of exercise capacity. In subgroup analyses, days of exercise per month were consistently higher across all strata of patients randomized to the intervention arm ().
In this pair of randomized controlled pilot trials of text message reminders delivered to post-MI patients participating in cardiac rehabilitation, we found significant improvement in both adherence to medications and the frequency and duration of exercise over 12 months of follow-up as measured by patient self-report. In addition, the secondary outcome of the trial focusing on exercise adherence showed a nonsignificant trend to improved cardiopulmonary fitness as measured by exercise stress testing.
Several studies have demonstrated the potential benefits of external reminders, including text messaging, for improving medication adherence [, ]. A recent meta-analysis of 16 randomized studies of adult patients with chronic disease, including coronary artery disease, HIV, and epilepsy, found that the odds of full adherence was more than doubled for those who received text messages [ ]. Of the studies included, only 3 explicitly studied patients taking medications for secondary prevention after acute coronary syndrome, of which only 2 were ultimately included in the meta-analysis [ , ]. Both studies followed patients for only 30 days, sending daily personalized reminders to patients in the intervention arms to take their cardiovascular medications. Moreover, neither of these studies was conducted within the context of a comprehensive post-MI cardiac rehabilitation program, in which approximately 40% of patients post-MI in the United States enroll [ - ], and which could conceivably have augmented or extinguished the impact of text message reminders. In contrast, our study, despite being small in size and conducted at a single center, found sustained improvements in medication-taking from text message reminders delivered in addition to cardiac rehabilitation, as compared with cardiac rehabilitation alone that persisted over the course of 12 months of follow-up.
Several studies have demonstrated the beneficial effects of text message reminders on exercise adherence among patients with heart disease [, , ]. For example, the TEXT-MI trial enrolled patients with documented cardiovascular disease and randomized them to usual care or to receive text messages that provided advice, motivational reminders, and support to change a wide range of lifestyle behaviors, one of which was physical activity [ , , ]. This trial found clinically meaningful and statistically significant improvements in exercise, low-density lipoprotein cholesterol, blood pressure, body mass index, and smoking even though follow-up ended after 6 months. A few existing studies have specifically enrolled patients in the immediate post-MI setting or have been conducted concurrently with cardiac rehabilitation. Frederix et al [ ] studied the impact of augmenting cardiac rehabilitation with a “tele-rehabilitation” program in which emails and texts were sent by a coach based upon patient’s individual accelerometer data. The intervention resulted in significant improvements in physical fitness and quality of life over 24 weeks of follow-up. In contrast, our intervention relied on fully automated messages, without the need to receive and process accelerometer data, and followed patients for 12 months. The improvements in self-reported exercise adherence translated to higher exercise tolerance, as measured by the BRUCE protocol exercise stress test administered at 12 months. Although these results did not reach statistical significance, they demonstrate a strong long-term trend that bears confirmation in a larger study.
There are many similarities between medication adherence and exercise adherence behaviors that suggest why a highly similar intervention may have been effective for both behaviors. In specific, medication and exercise adherence require daily engagement and have multiple barriers to their performance, including motivation, literacy or knowledge, or simple forgetfulness. Moreover, studies of text messaging to improve medication adherence or exercise adherence have reported high patient satisfaction, with the vast majority of patients reporting that the short message service messages were useful and easy to understand [, , ].
A greater drop-off in the days of exercise per month was noted in the control group at month 3. This corresponds to the end of the on-site cardiac rehabilitation program. For the first 3 months of cardiac rehabilitation, patients exercised on-site for 2 sessions per week. Following this, patients continued to exercise at home but did not exercise on-site. No similar drop-off was noted in the text message arm of the study.
In our subgroup analyses, we observed consistent effects of texting on medication and exercise adherence. Although we had hypothesized a priori that access and knowledge of the technology may have been a barrier to effective use of this intervention among the elderly, our observations revealed the contrary. These results are consistent with studies that found other electronic interventions to be as or more effective among older individuals [, ]. This being said, more research is required to confirm these results in larger and more diverse patient populations.
Patients were surveyed following the end of the study to discuss their experience with daily text message reminders. The majority reported that these reminders were helpful in maintaining adherence to their therapies and did not find them to be overly intrusive. They reported their preference for the text messages over alarms, which could be turned off more easily. Patients also reported liking that the reminders came from an outside source and likened them to calls from a nurse or other health care provider. More formalized polling of patient participants in future studies may provide further insight into patient experience with reminder systems such as the one examined in this study.
There are several limitations to our trials. First, both trials had small sample sizes and were conducted at a single cardiac rehabilitation facility in Ontario, Canada. Future studies with larger sample sizes could seek to evaluate other end points such as hospital readmissions. Data collected in this study were largely self-reported, although this has been the primary mode of outcome evaluation in the majority of existing studies evaluating text reminders on medication adherence . The fact that the improvement in exercise adherence we observed was correlated with objective improvements in aerobic fitness measured by stress testing suggests that our outcome measurement was reliable and any mismeasurement was nondifferential with respect to the exposure. Our medication adherence trial included only patients on once-a-day regimens of the four classes of medications studied. Whereas all four medication classes we studied are widely available with this dosing strategy, our results may not be generalizable to all post-MI patients. Additionally, most of the patients in the study had one or more chronic diseases and were taking medications for these diseases. The message sent to patients reminding them to take their medications read, “Please remember to take your morning medications now.” Although we expect this nonspecific messaging would have encouraged patients to take all of their therapies as prescribed, we only evaluated adherence to the four post-MI medications. Also, the long follow-up of the study during which no one dropped out and which required patients to complete logbooks on a daily basis may limit generalizability to other patient groups. In both trials, logbooks were used to measure medication and exercise adherence because this method, previously validated, was already in use at the cardiac rehabilitation center where we conducted the study, and we hoped to integrate study procedures into the cardiac rehabilitation program. It is possible that patients may have taken a medication or exercised but forgotten to log this in the logbook; however, we do not believe that this has significantly impacted our results [ ]. Finally, there were baseline imbalances in the treatment arms in potentially important characteristics, notably sex, although our overall results remained unchanged in multivariable and subgroup analyses. Further research should be conducted in larger and more diverse populations.
In conclusion, structured text message reminders were found to significantly improve adherence to both medications and exercise. Although further research is required to validate our results in larger and more diverse settings, text messaging appears to represent a simple and scalable strategy for improving adherence to medications and exercise among post-MI patients.
Conflicts of Interest
Multimedia Appendix 1
CONSORT-EHEALTH checklist (V1.6.1).PDF File (Adobe PDF File), 445KB
- Oliveira GB, Avezum A, Roever A. Cardiovascular disease burden: evolving knowledge of risk factors in myocardial infarction and stroke through population-based research and perspectives in global prevention. Front Cardiovasc Med 2015;2:32 [FREE Full text] [CrossRef] [Medline]
- Ford ES, Ajani UA, Croft JB, Critchley JA, Labarthe DR, Kottke TE, et al. Explaining the decrease in U.S. deaths from coronary disease, 1980-2000. N Engl J Med 2007 Jun 07;356(23):2388-2398. [CrossRef] [Medline]
- Langer Research Associates. National Community Pharmacists Association. 2013. Medication adherence in America: a national report card URL: http://www.ncpa.co/adherence/AdherenceReportCard_Full.pdf [WebCite Cache]
- Choudhry NK, Setoguchi S, Levin R, Winkelmayer W, Shrank W. Trends in adherence to secondary prevention medications in elderly post-myocardial infarction patients. Pharmacoepidemiol Drug Saf 2008 Dec;17(12):1189-1196 [FREE Full text] [CrossRef] [Medline]
- Fonarow GC, French W, Frederick P. Trends in the use of lipid-lowering medications at discharge in patients with acute myocardial infarction: 1998 to 2006. Am Heart J 2009 Jan;157(1):185-94.e2. [CrossRef] [Medline]
- Martin LR, Williams S, Haskard K, Dimatteo M. The challenge of patient adherence. Ther Clin Risk Manag 2005 Sep;1(3):189-199 [FREE Full text] [Medline]
- Gadkari AS, McHorney C. Unintentional non-adherence to chronic prescription medications: how unintentional is it really? BMC Health Serv Res 2012 Jun 14;12:98 [FREE Full text] [CrossRef] [Medline]
- Wroe AL. Intentional and unintentional nonadherence: a study of decision making. J Behav Med 2002 Aug;25(4):355-372. [Medline]
- Choudhry NK, Krumme A, Ercole P, Girdish C, Isaman D, Matlin O, et al. Rationale and design of the randomized evaluation to measure improvements in non-adherence from low-cost devices (REMIND) trial. Contemp Clin Trials 2015 Jul;43:53-59. [CrossRef] [Medline]
- Checchi KD, Huybrechts KF, Avorn J, Kesselheim AS. Electronic medication packaging devices and medication adherence: a systematic review. JAMA 2014 Sep 24;312(12):1237-1247 [FREE Full text] [CrossRef] [Medline]
- Rosen MI, Rigsby M, Salahi J, Ryan C, Cramer J. Electronic monitoring and counseling to improve medication adherence. Behav Res Ther 2004 Apr;42(4):409-422. [CrossRef] [Medline]
- Vervloet M, Linn AJ, van Weert JC, de Bakker DH, Bouvy ML, van DL. The effectiveness of interventions using electronic reminders to improve adherence to chronic medication: a systematic review of the literature. J Am Med Inform Assoc 2012;19(5):696-704 [FREE Full text] [CrossRef] [Medline]
- Zedler BK, Kakad P, Colilla S, Murrelle L, Shah N. Does packaging with a calendar feature improve adherence to self-administered medication for long-term use? a systematic review. Clin Ther 2011 Jan;33(1):62-73. [CrossRef] [Medline]
- Friedman RH, Kazis LE, Jette A, Smith MB, Stollerman J, Torgerson J, et al. A telecommunications system for monitoring and counseling patients with hypertension. Impact on medication adherence and blood pressure control. Am J Hypertens 1996 Apr;9(4):285-292. [Medline]
- Orrell C, Cohen K, Mauff K, Bangsberg DR, Maartens G, Wood R. A randomized controlled trial of real-time electronic adherence monitoring with text message dosing reminders in people starting first-line antiretroviral therapy. J Acquir Immune Defic Syndr 2015 Dec 15;70(5):495-502. [CrossRef] [Medline]
- Lauffenburger JC, Choudhry N. Text messaging and patient engagement in an increasingly mobile world. Circulation 2016 Feb 09;133(6):555-556 [FREE Full text] [CrossRef] [Medline]
- Thakkar J, Kurup R, Laba T, Santo K, Thiagalingam A, Rodgers A, et al. Mobile telephone text messaging for medication adherence in chronic disease: a meta-analysis. JAMA Intern Med 2016 Mar;176(3):340-349. [CrossRef] [Medline]
- Khonsari S, Subramanian P, Chinna K, Latif LA, Ling LW, Gholami O. Effect of a reminder system using an automated short message service on medication adherence following acute coronary syndrome. Eur J Cardiovasc Nurs 2015 Apr;14(2):170-179. [CrossRef] [Medline]
- Park LG, Howie-Esquivel J, Chung ML, Dracup K. A text messaging intervention to promote medication adherence for patients with coronary heart disease: a randomized controlled trial. Patient Educ Couns 2014 Feb;94(2):261-268. [CrossRef] [Medline]
- Quilici J, Fugon L, Beguin S, Morange PE, Bonnet J, Alessi M, et al. Effect of motivational mobile phone short message service on aspirin adherence after coronary stenting for acute coronary syndrome. Int J Cardiol 2013 Sep 20;168(1):568-569. [CrossRef] [Medline]
- Choudhry NK, Glynn R, Avorn J, Lee J, Brennan T, Reisman L, et al. Untangling the relationship between medication adherence and post-myocardial infarction outcomes: medication adherence and clinical outcomes. Am Heart J 2014 Jan;167(1):51-58. [CrossRef] [Medline]
- Centers for Medicare & Medicaid Services. 2014 Nov. Trends in part C & D star rating measure cut points URL: https://www.cms.gov/Medicare/Prescription-Drug-Coverage/PrescriptionDrugCovGenIn/Downloads/2015-Trends-in-Part-C-and-D-Star-Rating-Measure-Cut-Points-.pdf [accessed 2015-11-09] [WebCite Cache]
- NCQA.: National Committee for Quality Assurance Summary table of measures, product lines and changes URL: https://www.ncqa.org/Portals/0/HEDISQM/Hedis2015/List_of_HEDIS_2015_Measures.pdf [accessed 2015-10-12] [WebCite Cache]
- Bruce RA. Exercise testing of patients with coronary heart disease. Principles and normal standards for evaluation. Ann Clin Res 1971 Dec;3(6):323-332. [Medline]
- Bruce RA, DeRouen T, Peterson D, Irving J, Chinn N, Blake B, et al. Noninvasive predictors of sudden cardiac death in men with coronary heart disease. Predictive value of maximal stress testing. Am J Cardiol 1977 May 26;39(6):833-840. [Medline]
- Chow CK, Redfern J, Hillis GS, Thakkar J, Santo K, Hackett ML, et al. Effect of lifestyle-focused text messaging on risk factor modification in patients with coronary heart disease: a randomized clinical trial. JAMA 2015;314(12):1255-1263. [CrossRef] [Medline]
- Menezes AR, Lavie CJ, Milani RV, Forman DE, King M, Williams MA. Cardiac rehabilitation in the United States. Prog Cardiovasc Dis 2014 Apr;56(5):522-529. [CrossRef] [Medline]
- Dalal HM, Doherty P, Taylor R. Cardiac rehabilitation. BMJ 2015 Sep 29;351:h5000 [FREE Full text] [Medline]
- Jelinek MV, Thompson D, Ski C, Bunker S, Vale M. 40 years of cardiac rehabilitation and secondary prevention in post-cardiac ischaemic patients. Are we still in the wilderness? Int J Cardiol 2015 Jan 20;179:153-159. [CrossRef] [Medline]
- Maddison R, Whittaker R, Stewart R, Kerr A, Jiang Y, Kira G, et al. HEART: heart exercise and remote technologies: a randomized controlled trial study protocol. BMC Cardiovasc Disord 2011 May 31;11:26 [FREE Full text] [CrossRef] [Medline]
- Pfaeffli DL, Whittaker R, Dixon R, Stewart R, Jiang Y, Carter K, et al. Acceptability of a mobile health exercise-based cardiac rehabilitation intervention: a randomized trial. J Cardiopulm Rehabil Prev 2015;35(5):312-319. [CrossRef] [Medline]
- Pfaeffli DL, Whittaker R, Dixon R, Stewart R, Jiang Y, Carter K, et al. Acceptability of a mobile health exercise-based cardiac rehabilitation intervention: a randomized trial. J Cardiopulm Rehabil Prev 2015;35(5):312-319. [CrossRef] [Medline]
- Buckwalter KC, Wakefield B, Hanna B, Lehmann J. New technology for medication adherence: electronically managed medication dispensing system. J Gerontol Nurs 2004 Jul;30(7):5-8. [Medline]
- Mira JJ, Navarro I, Botella F, Borrás F, Nuño-Solinís R, Orozco D, et al. A Spanish pillbox app for elderly patients taking multiple medications: randomized controlled trial. J Med Internet Res 2014;16(4):e99 [FREE Full text] [CrossRef] [Medline]
- Jeffrey BA, Hannan M, Quinn E, Zimmerman S, Barton B, Rubin C, et al. Self-reported adherence with the use of a device in a clinical trial as validated by electronic monitors: the VIBES study. BMC Med Res Methodol 2012 Nov 14;12:171 [FREE Full text] [CrossRef] [Medline]
|METS: metabolic equivalents|
|MI: myocardial infarction|
|PDC: percentage of days covered|
Edited by L Buis; submitted 13.12.16; peer-reviewed by M Vervloet, J Gatwood, B Holtz; comments to author 03.02.17; revised version received 11.05.17; accepted 05.06.17; published 03.08.17
©Avinash Pandey, Alexis Krumme, Tejal Patel, Niteesh Choudhry. Originally published in JMIR Mhealth and Uhealth (http://mhealth.jmir.org), 03.08.2017.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in JMIR mhealth and uhealth, is properly cited. The complete bibliographic information, a link to the original publication on http://mhealth.jmir.org/, as well as this copyright and license information must be included.